NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma

Debora Soncini(University of Genoa), Michele Cea(Azienda Ospedaliera S.Maria), Fabio Guolo(Ospedale Policlinico San Martino), Roberto M. Lemoli(University of Genoa), Santina Bruzzone(Ospedale Policlinico San Martino), Sara Aquino(Ospedale Policlinico San Martino), Aimable Nahimana(University of Lausanne), Fiammetta Monacelli(Ospedale Policlinico San Martino), Gianluca Santamaria(TUM Klinikum), Adithya Chedere(Indian Institute of Science Bangalore), Pamela Becherini(University of Genoa), Matteo Garibotto(University of Genoa), Axel Bellotti(University Hospital of Lausanne), Elisa Gelli(Italian Institute of Technology), Luca Mastracci(Ospedale Policlinico San Martino), Antonia Cagnetta(Ospedale Policlinico San Martino), Claudia Martinuzzi(Ospedale Policlinico San Martino), Emanuele Angelucci(Ospedale Policlinico San Martino), Silvia Ravera(Ospedale Policlinico San Martino), Moustafa Ghanem(University of Genoa), Francesco Piacente(University of Genoa), Nagasuma Chandra(Indian Institute of Science Bangalore), Giulia Giorgetti(Dana-Farber Cancer Institute), Francesco Ladisa(Dana-Farber Cancer Institute), Michel A. Duchosal(Scripps Health), Mario Passalacqua(University of Genoa), Claudia Veneziano(Magna Graecia University), Alessio Nencioni(University of Genoa)
Blood Advances
December 11, 2024
Cited by 5


Related Papers